Patents by Inventor Jean-Claude Gromenil

Jean-Claude Gromenil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BENZOFURAN DERIVATIVES
    Publication number: 20170319538
    Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
    Type: Application
    Filed: July 26, 2017
    Publication date: November 9, 2017
    Inventors: Bernard ABRAMOVICI, Jean-Claude GAUTIER, Jean-Claude GROMENIL, Jean-Marie MARRIER
  • SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BENZOFURAN DERIVATIVES
    Publication number: 20160338989
    Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
    Type: Application
    Filed: May 6, 2016
    Publication date: November 24, 2016
    Inventors: Bernard ABRAMOVICI, Jean-Claude GAUTIER, Jean-Claude GROMENIL, Jean-Marie MARRIER
  • Solid pharmaceutical compositions containing benzofuran derivatives
    Patent number: 8318800
    Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: November 27, 2012
    Assignee: Sanofi
    Inventors: Bernard Abramovici, Jean-Claude Gautier, Jean-Claude Gromenil, Jean-Marie Marrier
  • Solid Pharmaceutical Compositions Containing Benzofuran Derivatives
    Publication number: 20080139645
    Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
    Type: Application
    Filed: December 13, 2007
    Publication date: June 12, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Bernard ABRAMOVICI, Jean-Claude GAUTIER, Jean-Claude GROMENIL, Jean-Marie MARRIER
  • Solid pharmaceutical composition containing benzofuran derivatives
    Patent number: 7323493
    Abstract: The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: January 29, 2008
    Assignee: Sanofi-Aventis
    Inventors: Bernard Abramovici, Jean-Claude Gautier, Jean-Claude Gromenil, Jean-Marie Marrier
  • Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates
    Patent number: 6893659
    Abstract: The pharmaceutical compositions for oral administration according to the invention contain 0.5% to 20% of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form, and pharmaceutical excipients; they are formulated by wet granulation.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: May 17, 2005
    Assignee: Sanoti-Synthelabo
    Inventors: Bernard Abramovici, Christian Condamine, Jean-Claude Gromenil
  • Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates
    Publication number: 20030003145
    Abstract: The pharmaceutical compositions for oral administration according to the invention contain 0.5% to 20% of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form, and pharmaceutical excipients; they are formulated by wet granulation.
    Type: Application
    Filed: May 1, 2002
    Publication date: January 2, 2003
    Inventors: Bernard Abramovici, Christian Condamine, Jean-Claude Gromenil
  • Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
    Patent number: 4980171
    Abstract: The invention relates to oral pharmaceutical compositions comprising a diphosphonic acid derivative and sodium laurylsulfate in the amount of 1.5 to 6% by weight, relative to the diphosphonic compound.
    Type: Grant
    Filed: April 6, 1989
    Date of Patent: December 25, 1990
    Assignee: Societe Anonyme dite : SANOFI
    Inventors: Jean-Pierre Fels, Jean-Claude Gromenil, Bernard Abramovici